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ABSTRACT 
Replication Protein A (RPA) is an evolutionary conserved essential complex with single-
stranded DNA binding properties that has been implicated in numerous DNA transactions. At 
damaged telomeres, Saccharomyces cerevisiae RPA recruits the Mec1-Ddc2 module of the 
DNA damage checkpoint network, its only known function in DNA damage signaling. Here, 
we describe rfa1 mutants (rfa1-1, rfa1-9, rfa1-10, rfa1-11 and rfa1-12) that are proficient in 
this checkpoint but nevertheless exhibit deregulation of cell cycle control upon telomere 
uncapping induced by the cdc13-1 mutation. Overriding of this damage-induced checkpoint-
independent cell cycle block in the rfa1 mutants was suppressed following genetic 
inactivation of either TEL1 or EST2/telomerase. Altogether, our results suggest that a 
previously non suspected function of RPA is to block cell cycle progression upon telomere 
uncapping using a yet unidentified pathway that functions in a Mec1-Ddc2-independent 
manner. We propose that in the rfa1 mutants, ill-masking of uncapped telomeres provokes 
inappropriate access of Tel1 and inappropriate functioning of telomerase, which, by yet 
unknown mechanisms, allows cell division to take place in spite of the block established by 
the DNA damage checkpoint. In the present study, we also observed that upon telomere 
uncapping, rfa1-12, but not the other studied rfa1 mutants, triggered telomeric recombination 
in the presence of functional telomerase. In conclusion, the present study identifies a novel 
pathway of telomere end protection that utilizes a previously unsuspected function of RPA at 
the telomeres. 
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1. Introduction 
Early in their discovery, telomeres, the extremities of eukaryotic linear chromosomes, were 
regarded as a protective cap that prevented fusion between chromosomes [1,2]. Confirming 
these early assumptions, it is now still widely accepted that the main function of telomeres is 
to protect the genome against the occurrence of all events that normally promote repair of 
intrachromosomal DNA breaks, homologous recombination and non homologous end-joining 
(NHEJ), principally, including DNA damage signaling and checkpoint operation [3,4]. It is 
worth stressing that the second main function of telomeres, namely recruiting telomerase for 
telomere replication, also represents a sort of telomere end protection as it allows to regularly 
add telomeric DNA sequences to the eroding telomeres of dividing cells [5]. Extensive 
studies on telomeric proteins from various organisms, starting in the 1990s, led to the notion 
that the association of these telomeric proteins with telomeric DNA provides efficient means 
for masking these natural DNA double-strand breaks (DSBs) from inappropriate repair. 
 To date, in various organisms, a number of telomeric proteins have been implicated in 
preventing access of various DNA modification proteins to the telomeres. In the budding 
yeast Saccharomyces cerevisiae, Rap1, which binds telomeric double-stranded DNA 
repeats, inhibits both telomerase-dependent telomere elongation and telomere fusions by 
NHEJ [6-8]. The Rap1-Rif1-Rif2 complex in fact functionally resembles shelterin, the 
telomere end protection complex in mammals [9]. The Yku complex, which plays a major role 
in NHEJ, also localizes at the telomeres, at the junction between the double-stranded and 
single-stranded DNA (ssDNA) repeats where it functions in telomere end protection [10]. 
Finally, another major component for telomere capping in S. cerevisiae is a heterotrimeric 
complex composed of Cdc13, Stn1 and Ten1 that binds the single-stranded overhangs of the 
telomeres [11-14]. Recent work has shown that Rif2 levels are reduced at short telomeres 
and that this is important for the recruitment of Mre11-Rad50-Xrs2 (MRX) and of Tel1 at 
these telomeres [15], an event leading to the recruitment of telomerase for re-elongation [16-
20]. By favoring telomerase recruitment, the reduction of Rif2 levels may therefore help 
distinguish short telomeres from DSBs [15]. In the same study, at short telomeres, Mec1 and 
Replication Protein A (RPA) levels were found to be strongly reduced compared to their 
levels at DSBs, thus providing a way to prevent putative DNA damage signaling and DNA 
repair attempts [15]. 
 RPA is a major, evolutionary conserved, ssDNA-binding complex that is essential for 
numerous transactions during DNA synthesis and DNA damage signaling and repair [21-24] 
everywhere in the genome including, in the budding yeast S. cerevisiae, at the telomeres 
[25]. The unique function of RPA in DNA damage signaling identified to date, in both humans 
and S. cerevisiae, is to recruit the ATR/ATRIP and Mec1-Ddc2 module of the DNA damage 
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checkpoint machinery, respectively [26]. Under normal circumstances, in cells with 
undamaged telomeres, Cdc13 prevents Mec1 activation [11] and, presumably therefore, 
RPA recruitment. However, it is not known yet whether Cdc13 acts primarily through limiting 
end resection or whether it also blocks, by competition, RPA binding to the telomeric ssDNA 
[4,14]. In humans, the interactions between POT1 and RPA have been better documented, 
with the recent discovery of a TERRA- and hnRNPs-based mechanism that can displace 
RPA, but not POT1, activity [27,28]. 
 It is crucial to fully understand the relationships between telomere uncapping and cell 
cycle progression as efforts to uncover the underlying mechanisms driving genome instability 
in cancer cells have revealed a prominent role for telomeres [29]. Telomere uncapping is not 
an unusual fate as, for instance, the numerous events leading to temomerase recruitment at 
the telomeres may provoke transient but necessary periods of loss of telomere end 
protection. DNA replication itself is susceptible to create telomeric damage resulting from 
pausing or even stalling of the replication forks in the telomeric regions due to the repetitive 
nature of the DNA sequences [30-32]. In the present study, to better understand the 
relationships between telomere uncapping and cell cycle progression we analyzed mutants 
of S. cerevisiae RPA, previously described [33], in a genetic context that has been 
extensively used as a mean to provoke telomere uncapping, namely the temperature-
sensitive cdc13-1 mutation [11]. 
 
2. Experimental procedures 
2.1 Yeast strains, viability assays and Western blotting 
Yeast strains used in this study were derivatives of BF264-15Daub (ade1 his2 leu2-3,112 
trp1-1a ura3Dns), as described previously [12]. Yeast cultures were grown at the indicated 
temperatures in YEP (1% yeast extract, 2% bacto-peptone, 0.005% adenine, 0.005% uracile) 
supplemented with 2% glucose (YEPD), sucrose or galactose, or in selective minimal 
medium. All strains were made isogenic by back crossing at least five times against our 
genetic background. Strain origins, prior to back crossing, were as described previously [34]. 
 Construction of the rfa1 mutants analyzed here has been described previously [33]. 
Activation of the checkpoint kinase Rad53 was assessed by Western blotting as described 
previously [33]. 
 The viability of cells previously grown in liquid was determined by performing and 
analyzing the so-called “drop tests” or “spot assays”. To do this, cells from exponential 
growth cultures were counted with a hematocytometer and the cultures were then serially 
diluted by 1/5th or 1/10th and spotted onto either selective plates or YEPD non-selective 
plates, as required, and incubated at the desired temperature for 2-3 days before being 
photographed. 
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2.2 Telomere length measurement, telomere organization and detection of ssDNA 
Assessment of telomere length and telomere organization in cells with either non 
recombining or recombining telomeres was done as described previously [12]. Briefly, 
genomic DNAs were prepared, separated in a 0.9% agarose gel (in TBE) run in TBE buffer 
overnight and, after denaturation, transferred and hybridized with a 270 base pair TG1-3 
32P-
labeled telomeric probe as described previously [12]. Following digestion of genomic DNA 
with XhoI, to cut within the Y’ regions of chromosomes, telomere tracts of wild-type cells 
appear as a broad band of ~ 1.1-1.4 Kb which represents the average length of most 
chromosomes. Telomeric recombination was assessed as previously described [37]. 
Detection of ssDNA at the telomeres was performed as described previously [13,34]. Results 
were analyzed using an FLA-5100 Fuji phosphorimager or a GE Storm phosphorimager and 
the ImageGauge software. 
 
3. Results 
3.1. rfa1 mutants defective in telomeric damage-induced cell cycle progression 
independently of the DNA damage checkpoint 
Temperature-sensitive cdc13-1 mutant cells of Saccharomyces cerevisiae exhibit uncapped 
telomeres under the form of abnormally high levels of ssDNA in both telomeric and 
subtelomeric regions of the chromosomes [11]. There is both genetic and biochemical 
evidence that RPA is recruited at cdc13-1-induced telomeric DNA damage sites [25,26]. Yet, 
although RPA recruited at DSBs mediates repair by homologous recombination [35], the 
cdc13-1 cells do not trigger recombination or any other apparent signs of repair. In 
agreement with this view, cdc13-1 cells experiencing telomeric recombination due to 
inactivation of telomerase could now grow at the semi-permissive temperature of 29°C 
(Figure 1A, B). Presumably, in these cells telomeric recombination provided some sort of 
DNA repair, as observed in post-senescence survivors from telomerase-negative cells [36]. It 
has been previously established that the slow growth of cdc13-1 cells at 29°C, as well as the 
total arrest of proliferation at temperatures above 32°C, was due to activation of the Mec1-
Rad53-Mec3 DNA damage checkpoint network, which induces a block to cell cycle 
progression [11]. Thus, as shown by Hartwell and colleagues [11] and subsequently by 
several other laboratories, telomerase-positive cdc13-1 cells in which the DNA damage 
checkpoint had been inactivated exhibited improved growth at 29°C (Figure 1C; override of 
the arrest by the rad24 mutation; compare rows 1 and 2; Rad24 is a component of an RFC-
like complex that is essential for loading the Mec3-Ddc1-Rad17 checkpoint complex). 
 We previously isolated rfa1 mutants that, in a telomerase-negative background, were 
specifically deficient in type I telomeric recombination on the Y’ subtelomeric sequences (but 
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not in type II recombination on the TG1-3 repeats) but proficient in activating the DNA damage 
checkpoint [33]. In the current study, we analyzed these rfa1 mutants (see mutations in 
Table 1) in a cdc13-1 background. The rfa1-1, -9, -10, -11, and -12 mutants rescued cdc13-1 
at 29°C in a way similar (although to different extents) to the checkpoint-deficient mutants 
rfa1-t11 and rad24 (Figure 1C; note that rfa1-12 was not deficient in type I recombination 
but was used, in the previous study, as a negative control; ref. 33). rfa1-t11, first described in 
ref. 35, was later shown, in the cdc13-1 background, to be checkpoint-deficient [25], the 
mutant protein being defective in recruiting the Mec1-Ddc2 checkpoint complex [26]. 
Therefore the rfa1-t11 and rad24 mutations each impinge on one of two parallel pathways 
of the same checkpoint network, thereby explaining their similar phenotypes upon cdc13-1-
induced damage (Figure 1C). Surprisingly, the rfa1 mutants from our previous study [33] 
analyzed here, although failing to arrest upon damage (Figure 1C; compare rows 1, 2 and 3-
7), were still proficient in activating the DNA damage checkpoint, as judged by full activation 
of Rad53, a pivotal protein kinase essential for this checkpoint (Figure 2A), thus confirming 
our previous analysis [33]. To further document this apparent contradiction, we set out to 
genetically inactivate a component of the DNA damage checkpoint pathway in the cdc13-1 
rfa1 double mutants. The rationale for these experiments was that simultaneously 
inactivating two checkpoint genes in the same DNA damage response pathway does not 
provoke a more severe checkpoint defect than inactivating either one of these two same 
genes (see, for instance, ref.37,38). Combining an rfa1 mutation with a mutation in a gene of 
the checkpoint network, here MEC3, resulted in a clear additional effect in the cdc13-1 
background, an effect that was best visible at 30°C (Figure 2B). 
 Simple observation of the checkpoint-deficient cdc13-1 rad24and cdc13-1 rfa1 
mutants under the light microscope evidenced two different types of arrest existing (Figure 
2C). In seminal papers that led to the discovery of a DNA damage checkpoint pathway in all 
eukaryotic cells, Hartwell and colleagues observed that checkpoint-negative cdc13-1 double 
mutants failed to arrest in the G2 phase and died rapidly after a few cell divisions following 
shift to the restrictive temperature [37,39,40]. After 2 h at 34°C, cdc13-1 rad24 mutant cells 
indeed exhibited the behavior previously described by these authors, while the cdc13-1 rfa1-
9 mutant did not, and, instead, arrested in the G2 phase very much like the checkpoint-
proficient cdc13-1 mutant (Figure 2C). This strongly suggested that the mechanisms 
deregulated in the rfa1 mutant are not the same as those deregulated in the classical 
checkpoint mutant. 
 It is important to note that checkpoint deficiency leading to improved growth is specific 
for the cdc13-1 mutation and is usually explained by the fact that, at semi-permissive 
temperatures for growth, the telomeric DNA damage is not too severe and can be tolerated 
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through many rounds of cell divisions [11,37,41]. However, this is different in a large number 
of other DNA-damaging backgrounds tested, such as the temperature-sensitive cdc17-1 
mutant, in which abrogation of the checkpoint results in a decrease in cell viability as 
temperature increases [37]; CDC17 codes for the catalytic subunit of the DNA polymerase 
alpha-primase complex; ref. 42,43). Interestingly, while the ddc1 mutation and the rfa1-t11 
mutations, both abrogating the DNA-damage checkpoint, decreased cdc17-1 cell survival at 
the semi-permissive temperature of 32°C, the rfa1-12 mutation had no effect, further 
suggesting that this mutant is not deficient in DNA-damage checkpoint (Figure 2D). 
 In summary, by biochemical (Fig. 2A), genetic (Fig. 2B, D) and morphological (Fig. 
2C) criteria, the data above established that upon cdc13-1-induced telomeric DNA damage 
the rfa1-1, -9, -10 and -12 mutations, although provoking a deregulation in cell cycle arrest 
apparently similar to that in DNA damage checkpoint mutants (Figure 1C), nevertheless did 
not impinge on the same targets for controlling cell cycle progression. 
 
3.2 Rescue of cdc13-1 by rfa1-1, -9, -10, or -12 is not due to a decrease in DNA damage 
The 5’ to 3’ double-stranded DNA EXO1 exonuclease is the main exonuclease -and only one 
identified to date- responsible for telomeric CA strand digestion [44-46], creating the long TG 
ssDNA overhang in cdc13-1 cells at restrictive temperature that is at least part of the damage 
sensed by the DNA-damage checkpoint [11]. Potentially, the rfa1 mutants analyzed here 
could rescue cdc13-1 growth by preventing access of Exo1 to telomeric DNA, thereby 
decreasing the amount of damaged telomeric DNA. As expected from previous results [44], 
deleting EXO1 partially rescued cdc13-1 cells at 29°C (Figure 3A, compare rows 1 and 6), to 
the same extent as the rfa1 mutants and the DNA-damage checkpoint mutants. We 
reasoned that if the Rfa1 mutant protein acted through Exo1 to rescue cdc13-1 (in other 
words if the rfa1 mutation led to inactivation of Exo1), then the triple cdc13-1 rfa1 exo1 
mutant would grow like the double cdc13-1 rfa1 and the cdc13-1 exo1 double mutants. 
However, on the contrary, we observed that the triple cdc13-1 rfa1 exo1 mutants grew 
better than the two corresponding double mutants (Figure 3A, compare rows 7-10 to row 6). 
These data strongly suggested that in the rescue of cdc13-1 these rfa1 mutations were not 
acting by preventing Exo1 access to telomeric DNA. 
 To confirm the data above by a distinct approach, we prepared genomic DNAs from 
the cdc13-1, cdc13-1 mec3, cdc13-1 rfa1-t11, cdc13-1 exo1 and cdc13-1 rfa1 mutants 
and set out to detect telomeric ssDNA in these cells after growth at the restrictive 
temperature of 34°C by applying native conditions of hybridization to the telomeric probe. For 
the denatured control gel, the genomic DNA was digested with EcoRI instead of the more 
commonly used XhoI enzyme, because the EcoRI site is more centromere-proximal than the 
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XhoI site, releasing telomeric fragment of ~ 4.0 Kb instead of ~ 1.2 Kb for XhoI. Therefore, 
the EcoRI site is far enough from the telomeric ssDNA for the enzyme to cut efficiently. On 
the native gel, the XhoI-digested DNA displayed the classical smear characteristic of 
abnormal accumulation of telomeric ssDNA induced by the cdc13-1 mutation [11] in all 
strains, except for the cdc13-1 exo1 and cdc13-1 exo1 rfa1-12 strains, (Figure 3B), as 
expected from the genetic data of Figure 3A. Therefore, these rfa1 mutants do not prevent 
telomeric degradation by Exo1 and, more generally, do not appear to lead to a diminution of 
cdc13-1-induced telomeric DNA damage. 
 
3.3 The rfa1-12 mutation can trigger immediate telomeric recombination at uncapped 
telomeres 
As explained above and illustrated in Figure 1A, B, telomeric recombination can repair the 
cdc13-1-induced telomeric damage. Inferring that the rescue of cdc13-1 by the analyzed rfa1 
mutants could possibly be due to recombination-dependent telomere repair, we looked at the 
structure of telomeres in these strains by Southern blot. Telomeres of otherwise wild-type 
cells were normal in the rfa1 mutants (Figure 4A, left lanes). In the cdc13-1 background and 
at the permissive temperature of 24°C, telomeres tended to be shorter than those in the wild 
type (with the exception of cdc13-1 rfa1-1), but still homogenous in length (Figure 4A, right 
lanes). We then grew the cdc13-1 rfa1 mutants at semi-permissive temperature (29°C) for 
several generations to give the telomeres time to be processed by the DNA repair activities 
induced by the cdc13-1 damage. In this experiment, control mutant strains also capable of 
growth at semi-permissive temperature, such as cdc13-1 mec3 (checkpoint-deficient; [37], 
cdc13-1 bmh1 [47] and cdc13-1 exo1 [44] were included. After reaching equilibrium at 
29°C, telomeres in the cdc13-1 rfa1-1, -9 and -10 mutants were of various length depending 
on the mutation, but without excessive lengthening or shortening (Figure 4B) and somewhat 
more heterogeneous in length than at 24°C (compare Figure 4A right lanes and Figure 
4B). At 29°C, the telomeres in cdc13-1 rfa1-1 tended to be longer than in the wild type and 
those in both the cdc13-1 rfa1-9 and in cdc13-1 rfa1-10 tended to be shorter than in the wild 
type, just like at 24°C (Figure 4A). 
 In sharp contrast with the other three mutants, the cdc13-1 rfa1-12 mutant exhibited 
clear disorganization of telomere organization, much more dramatic than simple variations in 
length or homogeneity, which, interestingly, resembled a classical profile of type II 
recombination (Figure 4B; ref. 48-50). Data presented below indeed established that 
telomeric recombination takes place in the cdc13-1 rfa1-12 mutant at 29°C. 
 
3.4 Improved growth in cdc13-1 rfa1-12 can take place in the absence of telomeric 
recombination 
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We were intrigued by the fact that the rfa1-1, rfa1-9 and rfa1-10 mutants also exhibited 
improved growth at 29°C in the cdc13-1 background even though their telomeres were not 
recombining, as shown above in Figure 4B. We therefore next asked whether the rescue of 
cdc13-1 growth by rfa1-12 was indeed caused by telomeric recombination, as can be found 
under other circumstances (Figure 1A, B). Type II telomeric recombination depends on 
Rad52, a protein essential for basically all types of recombination, and the Mre11-Rad50-
Xrs2 (MRX) complex [36,48,49]. A diploid bearing the desired heterozygous mutations, 
CDC13/cdc13-1 RFA1/rfa1-12 RAD52/rad52, was induced to sporulate and the drop test-
based growth assays of the strains with the desired genotype performed as soon as possible 
after spore selection. After 3 days of growth following spore selection, rescue of cdc13-1 by 
the rfa1-12 mutation at 27.5°C could be readily observed (Figure 5A, compare rows 1 and 
3). Most importantly, this rescue was not inhibited by the absence of Rad52 (Figure 5A, 
compare rows 3 and 4). We prepared genomic DNAs from these cells at day 3 
(corresponding to the time at which the drop tests of Figure 5A were completed, day 0 being 
the time when the spore selection process was completed) and, in parallel, let these cells 
grow for 2 and 4 more days at 27.5°C before preparing their genomic DNAs for telomere 
structure analysis by Southern blot (Figure 5B). As expected, after 3 days of growth (day 3 
defined above) the cdc13-1 rfa1-12 cells did not exhibit a recombining telomeric profile 
(Figure 5B, day 3). It was only at day 7 that the presence of a large smear of telomeric DNA 
attested that recombination had started (Figure 5B, day 7, left lane). Actual recombination in 
the cdc13-1 rfa1-12 cells was confirmed by the disappearance of that smear when RAD52 
had been deleted (Figure 5B, day 7, right lane). Therefore, at early times following strain 
construction the cdc13-1 rfa1-12 cells grew at 27.5°C (Figure 5A) while their telomeres had 
not yet started to recombine, as attested by Southern analysis (Figure 5B). In summary, 
cdc13-1 rad52 rfa1-12 cells with no sign of telomeric recombination or cdc13-1 RAD52+ 
rfa1-12 cells prior to initiation of telomeric recombination, at day 3, nevertheless exhibited 
deregulated growth upon telomere uncapping, leaving us with the possibility for other 
mechanism being deregulated in the rfa1 mutant. 
 
3.5 Improved growth in cdc13-1 rfa1 requires Tel1 kinase activity as well as Est2/telomerase 
Following thorough analyses of genetic interactions, in a cdc13-1 background, between the 
rfa1 mutations studied here and mutations in genes previously implicated in telomeric 
pathways, we observed that, at semi-permissive temperatures for growth for cdc13-1, 
inactivation of TEL1 partially suppressed cdc13-1 rescue by rfa1-1 and totally suppressed 
that by rfa1-12 (Figure 6A). To know whether the suppression of cdc13-1 rfa1 rescue by 
Tel1 required its kinase activity, we modified the wild-type TEL1 chromosomal locus for 
expression of a tel1-kd mutation [51]. Inhibition of Tel1 kinase activity inhibited the rescue of 
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cdc13-1 by all rfa1 mutants to various extents, the effect being stronger for rfa1-12 (Figure 
6B, top panels). The absence of a synthetic defect between the tel1-kd and rfa1 mutants in 
an otherwise wild-type background suggested that the genetic interactions observed 
between the rfa1 and tel1 mutations are linked to telomere protection and not to some other 
more general effect (Figure 6B, bottom panel). 
 Because Tel1 has been shown to mediate telomere elongation by telomerase at short 
telomeres, a reaction that appears to involve the initial recruitment of MRX at these ends 
followed by transient association with Tel1 [17-19], we performed experiments using the 
est2-DF338 mutation, which displays short telomeres, decreased telomerase activity and 
decreased binding to TLC1 [52]. The est2-DF338 mutation exhibited only slight synthetic 
growth defects in combination with cdc13-1 (Figure 6D, bottom left panel, compare rows 2 
and 3, at 24°C). The short telomere phenotype conferred by the est2-DF338 mutation in 
different backgrounds is shown in Figure 6C. When combined with the cdc13-1 rfa1 
mutations, the est2-DF338 mutation suppressed the rescue of cdc13-1 by the rfa1 mutations 
(Figure 6D). 
 We tested the effects of the mre11 and yku70 null mutations on the growth 
characteristics of the cdc13-1 rfa1 mutants. However, since both mre11 and yku70 
exacerbated the growth defects conferred by cdc13-1, as previously reported by several 
other laboratories, this rendered the interpretation of the drop test-based growth assays of 
the strains difficult (data not shown). 
 
3.6 Telomere elongation in telomerase-negative cells does not confer cdc13-1 rfa1-12 
improved growth 
One possible interpretation of the data above was that telomerase-mediated telomere 
elongation might be responsible for the deregulated growth of these rfa1 mutants upon 
telomere uncapping. To further challenge this hypothesis, we reasoned that it would be 
interesting to find a way to achieve the same goal as that resulting from telomerase 
functioning, namely synthesizing telomere repeats, but in the absence of telomerase. In 
budding yeast, an alternative pathway for adding TG1-3 repeats at the ends of telomeres is 
through the so-called type II pathway of telomeric recombination that takes place in 
telomerase-negative post-senescence survivors [36,49]. Type I survivors can also be 
generated in these mutants but they amplify the sub-telomeric repeats rather than the TG1-3 
repeats [49]. In fact, the cdc13-1 background induces 100% type II [53]. We constructed 
several cdc13-1 tlc1 rfa1 strains as well as the cdc13-1 tlc1 RFA1+ as a control (TLC1 
encodes the telomerase RNA subunit) and let them grow for over 100 generations, past the 
time required for the cells to enter telomeric senescence, around 75 generations. As 
expected, telomeric recombination bypassed senescence in a minority of cells and post-
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senescence survivors were generated [36,54], of type II in the present situation. As shown in 
Figure 7, both the cdc13-1 tlc1 rfa1 and cdc13-1 tlc1 RFA1+ cells could grow at 29°C. 
This was expected as telomeric recombination rescues the cdc13-1 mutation as shown in 
Figure 1A. However, interestingly, the rfa1 mutant cells did not grow better than the RFA1+ 
cells, indicating that in the absence of telomerase the rfa1 mutations no longer confer growth 
advantage (Figure 7). To make sure that some aspect of telomerase activation was not 
taking place in the absence of TLC1 via the Est2 catalytic subunit, we also performed the 
analysis by simultaneously introducing the est2-DF338 mutation and obtained the same 
result ((Figure 7). Therefore, the rfa1 mutations no longer confer cdc13-1 cells a growth 
advantage in the absence of functional telomerase. 
 
4. Discussion 
The present work reveals two novel important functions for S. cerevisiae RPA, one in 
protection against inappropriate telomere recombination, the second one in preventing, upon 
telomere uncapping, cell proliferation by a checkpoint-independent pathway. 
 S. cerevisiae RPA has been shown to assume a function in telomere length control 
and telomerase recruitment [55-57]. However, to our knowledge, RPA has never been shown 
before to play a role in preventing telomeric recombination. The interpretation of our data 
(Fig. 4) attesting to a role of RPA in telomere end protection is straightforward. Indeed, as 
shown previously for other telomere end protection proteins, notably Cdc13 and the Yku 
complex [14], in the presence of telomere damage, the Rfa1-12 (L227S) protein triggered 
type II recombination. Note that the nature of telomere uncapping provoked here, namely the 
temperature-sensitive cdc13-1 mutation, has been previously shown to produce 100% type II 
recombination [53]. Therefore, it is not known yet whether RPA also protects subtelomeric 
sequences from undergoing inappropriate recombination. In general, in budding yeast, two 
situations have been reported to be associated with the triggering of telomeric recombination 
and the preceding announcing events, namely telomeric senescence. The more frequent one 
is the combination of mutations in two telomere end protection proteins, such as cdc13-1 and 
yku70 for instance [58]. It is not currently known whether the rfa1-12 mutation by itself 
creates telomeric damage. The second situation that was found to associate with telomere 
recombination was when loss of telomere capping, again provoked by the cdc13-1 mutation, 
was accompanied by inactivation of the G2/M DNA damage checkpoint [34]. Although the 
rfa1-12 mutation does not confer a defect in that checkpoint, its implication in a parallel 
pathway of cell cycle control, as documented in the present study, makes the scenario 
observed with cdc13-1 mec3 mutants, for instance [34] also likely to happen with cdc13-1 
rfa1-12. 
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 In view of the present data, RPA appears to represent a previously unsuspected key 
factor capable of operating a switch between telomerase-based telomere maintenance and 
recombination-based telomere maintenance, also known as the ALT pathway. Recent data 
obtained in mice have suggested that the system of telomere maintenance present at a given 
time, telomerase or ALT, might represent an unstable equilibrium that can easily shift from 
one system to the other when certain proteins, for instance the RTEL1 helicase, the DNA 
damage checkpoints or telomerase itself have been compromised [59,60]. At present, there 
is no evidence that RPA can play major roles in tumor initiation or progression as a result 
from telomeric disturbances. In fact, to our knowledge, mutations in RPA have not been 
directly associated with cancer, with the exception of a report that mice engineered to 
heterozygously express RPA1 L221P displayed elevated rates of cancer [61]. This was 
probably due to the L221P mutation conferring defects in checkpoints and homologous 
recombination, as seen in yeast with the equivalent mutation [62]. 
 The present data represent further analysis of previously described rfa1 mutants, 
rfa1-1, rfa1-9, rfa1-10, rfa1-11 and rfa1-12 [33]. Importantly for the comprehension of the 
present work, these mutations were shown to be resistant to methylmethane sulfonate 
treatment, like the wild type but unlike ddc1 and rad51, and were therefore presumed to 
be proficient in DNA repair [33]. Here, these mutants have been shown to confer 
deregulation of the cell cycle arrest that is normally triggered upon telomere uncapping, 
provoked by the temperature-sensitive cdc13-1 mutation. This should not have been 
surprising, since a similar phenotype had already been reported concerning the rfa1-t11 
mutant ([25]; see also Fig. 1C). Suppression of cdc13-1 arrest by the rfa1-t11 mutation has 
been shown to be due to an inability for the Rfa1-t11 protein to recruit the Mec1-Ddc2 
checkpoint complex [26]. However, suppression of cdc13-1 arrest by the rfa1 mutations 
analyzed here was nevertheless surprising since these mutants were previously reported to 
be checkpoint proficient, in this same genetic background [33], as we confirmed here (Fig. 
2A). By genetics, we further demonstrated here that these Rfa1 mutant proteins acted in a 
separate pathway than that controlled by the Mec1-Rad53-Mec3 DNA damage checkpoint 
(Fig. 2B). In fact, this was obvious when examining the morphology of the mutant cells of the 
RPA pathway and comparing with that of the mutant cells of the checkpoint pathway (Fig. 
2C). Assessment of telomeric damage strongly suggested that these cdc13-1 rfa1 mutants 
did not accumulate less damage than the cdc13-1 RFA1+ mutant, which could have 
explained their improved growth, and did not impinge on the Exo1 pathway of damage 
generation (Fig. 3). 
 Initially, to try to explain the checkpoint-independent override of the cell cycle 
progression in the cdc13-1 rfa1 mutants, we reasoned that cell cycle control proteins should 
be suspected of being involved. In S. cerevisiae, besides with Mec1-Ddc2, RPA has never 
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been implicated in physical or functional interactions with proteins of control of the cell cycle, 
with the notable exception of the report of a physical interaction between Rfa1 and Cdc20 by 
affinity capture mass spectrometry in a high-throughput study [63]. We have investigated that 
possibility but have been so far unable to confirm this interaction by two hybrid or to 
recapitulate it by in vivo co-immunoprecipitation between chromosomally expressed Myc2-
Cdc20 and HA2-Rfa1 (Grandin and Charbonneau, unpublished results). 
 In parallel, a thorough genetic analysis using combinations of the rfa1 mutations 
analyzed here and mutations in proteins involved in telomeric pathways led us to the 
surprising conclusion that deregulation of the cell cycle arrest in the cdc13-1 rfa1 mutants 
could be strongly suppressed by inactivating either TEL1 or EST2 (Fig. 6). Mre11 and Tel1 
cooperate in the recruitment of telomerase at short telomeres [17-20]. It is therefore 
reasonable to conclude that either a lack of telomerase loading (directly through the est2-
DF338 mutation or indirectly through the tel1 mutation) or shorter than normal telomeres 
could lead to suppression of checkpoint-independent cell cycle control deregulation in cdc13-
1 rfa1. Unfortunately, we have been unable to rigorously test the effects of mutations in the 
MRX and Yku complexes due to synthetic growth defects with cdc13-1. Additional 
experiments in telomerase-negative post-senescence survivors (Fig. 7) indicated that the 
requirement of the rfa1 phenotype (deregulation of cell cycle control upon damage) for 
telomeric repeats addition by telomerase could not be mimicked by addition of these repeats 
by telomere recombination. We propose that wild-type RPA normally prevents cell cycle 
progression upon telomere uncapping by two parallel pathways. One is the already 
described pathway of recruitment of an essential module of the DNA damage checkpoint 
machinery, Mec1-Ddc2 [26]. The second one might be to block telomerase action in order to 
prevent further addition of telomeric repeats. Addition of telomeric repeats can provide 
healing, for instance at DSBs, a reaction that is normally prevented by specific proteins, such 
as Pif1 [64]. However, in the present situation, potential healing by telomere repeat addition 
would not prevent telomere uncapping in the long term, the damage being persistent due to 
the continuous application of the cdc13-1-mediated insult. In fact, we have seen that the 
telomeric damage is not less in the rfa1 mutants, at least at 34°C (Fig. 3B). However, it is 
possible that unscheduled functioning of telomerase at intervals simultaneously at one or 
more uncapped telomeres could give the cells a sort of short respite from ongoing damage, 
respite that would be immediately followed by insult, thus undetectable at least with the 
sensitivity allowed by our measurements. In the cdc13-1 rfa1 mutants, such short bursts of 
telomeric repeats addition might confer regular periods of relief allowing in the end improved 
cell proliferation compared with the RFA1+ counterpart. 
 Particularly noteworthy are the F238 and F269 mutations found in rfa1-11 and rfa1-
10, respectively, that are conserved aromatic residues that make direct contact with ssDNA 
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[65]. These mutations may alter the ssDNA binding properties and affinity of RPA, its most 
important and fundamental attribute, and influence the telomeric pathways in which RPA is 
involved. In damaged cells, ill-positioned mutant RPA might give inappropriate access to 
Tel1. By blocking access of Tel1 at uncapped telomeres, wild type RPA might assume a 
function of marking the telomere for repair rather than for elongation by telomerase. 
Alternatively, RPA might directly bind telomerase to prevent it from being active in the 
presence of telomeric damage. This hypothesis is particularly interesting given the recently 
described physical interaction between RPA and telomerase in budding yeast [57]. We have 
been unable to test this hypothesis as we could not detect physical interaction between 
chromosomally expressed Myc18-Est2 and HA2-Rfa1 or HA2-Rfa1-12 (Grandin and 
Charbonneau, unpublished results). Because we clearly detect each of these proteins upon 
immunoprecipitation but not attached to each other neither at normal or uncapped telomeres 
(Grandin and Charbonneau, unpublished results), we believe that a putative RPA-telomerase 
physical interaction is not key in underlining the deregulation of the rfa1 mutants described 
here. 
 At the telomeres, RPA is physically present next to other ssDNA-binding proteins, 
such as Cdc13 and POT1, and assumes important roles in order to allow the coordinated 
completion of both telomere replication and telomere end protection [28]. The present data 
on the role of RPA in telomere end protection in S. cerevisiae will hopefully contribute to the 
elucidation of these pathways. 
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Legends of figures 
Figure 1. Mutants of RFA1 deregulated in telomere uncapping-induced cell cycle arrest. (A, 
B) Telomeric recombination, induced here by inactivating TLC1, coding for the RNA subunit 
of telomerase, partially rescued the temperature sensitivity of the cdc13-1 mutation (A), an 
event accompanied by telomeric recombination assessed by Southern blot (B). The smear at 
1.3-1.4 Kb represents the average length of the telomeres. The pattern of recombination is 
typical of type II recombination, amplifying the TG1-3 telomeric repeats [49]. Note that in the 
cdc13-1 background, type II is the only pathway permitted [53]. (C) Deregulation of cell cycle 
control upon cdc13-1-induced telomere uncapping was compared in checkpoint-deficient 
mutants, rad24 deletion and rfa1-t11, and other rfa1 mutants. All rfa1 mutants were under the 
control of natural promoter in a low-copy plasmid (centromeric, of the YCplac series, 
expressed at one or two copies per cell; ref. 66,67) in an rfa1 deletion background (RFA1 is 
an essential gene). Last row corresponds to the rfa1 deletion strain transformed with wild-
type RFA1 as a control. Shown schematically is the fate of cdc13-1 mutant cells with or 
without an intact checkpoint at the indicated temperatures. 
 
Figure 2. The DNA damage checkpoint is intact in telomere-uncapped cdc13-1 rfa1 mutant 
cells. (A) Activation of the checkpoint kinase Rad53 upon cdc13-1-induced telomere 
uncapping (2 h, 34°C) was assessed by visualizing electrophoretic mobility shifts of the 
protein [68]. Strains expressed RAD53-HA2 from the RAD53 genomic locus under the control 
of native promoter and the protein was detected following immunoprecipitation and Western 
blotting using monoclonal anti-HA antibody. The cdc13-1 mec1 sml1 deletion, cdc13-1 mec3-
2 and cdc13-1 rad9 deletion mutants served as controls, Mec1, Mec3 and Rad9 being 
essential for Rad53 activation. All cdc13-1 rfa1 mutants behaved like checkpoint-proficient 
cdc13-1 cells and cdc13-1 cells harboring wild-type RFA1, thus indicating an absence of 
Rad53-mediated checkpoint defect in these mutants. cdc13-1 rfa1-t11 mutant cells were 
partially defective in activating Rad53, as described previously [25]. (B) In cell viability 
assays, deregulation in damage-induced cell cycle control provoked by the rfa1 mutations 
(improved growth at 29°C compared with cdc13-1 alone) was found to be additive with the 
deregulation provoked by checkpoint inactivation in the mec3 deletion background, as 
combination of mec3 and rfa1 mutations (cdc13-1 mec3 rfa1 triple mutants) rendered this 
deregulation more severe than in either class of the double mutants, an effect best seen at 
30°C. (C) At the restrictive temperature for growth for cdc13-1 of 34°C, the arrest of 
checkpoint-deficient cells, here cdc13-1 rad24, differed from that in cdc13-1 rfa1-9, thus 
suggesting that the reasons for improved growth at 29°C (see Figure 1) were not the same 
for the two strains. cdc13-1 rad24 cells exhibited a typical override of the DNA damage-
induced block to cell cycle progression, indicated by re-budding, while the cdc13-1 rfa1-9 
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cells continued to enlarge in size without re-budding. (D) The growth defects of the 
temperature-sensitive cdc17-1 mutant (Cdc17 is a subunit of DNA polymerase alpha-
primase) were exacerbated by the checkpoint-deficient ddc1 and rfa1-t11 mutations, but not 
by the rfa1-12 mutation, thus suggesting that the later mutation unlike the former two ones 
does not confer defect in sensing the damage at the replication forks provoked by cdc17-1. 
 
Figure 3. The rfa1 mutations do not rescue cdc13-1 by diminishing Exo1-induced telomeric 
DNA degradation from double- to single-stranded. (A) Cell viability assays (spot tests) of 
cdc13-1 mutant strains of the indicated relevant genotypes at the indicated temperatures. 
The triple cdc13-1 rfa1 exo1 mutant grew better than the double cdc13-1 rfa1 and the 
cdc13-1 exo1 double mutants, an effect best visible at 30°C, suggesting that the rescue of 
cdc13-1 by the rfa1 mutations did not depend on Exo1. (B) Detection of abnormally high 
levels of telomeric ssDNA in the cdc13-1 strains of the indicated relevant genotypes, 
following growth at 34°C for 2 h, was performed by Southern blot analysis under native 
conditions (right panel). Only strains harboring the exo1 mutation exhibited a clear 
diminution of telomeric damage, thus indicating that the rfa1 mutations do not rescue cdc13-
1 through a failure to activate Exo1. 
 
Figure 4. The rfa1-12 mutation triggers telomeric recombination in cdc13-1 cells with 
uncapped telomeres. (A) Cells expressing the indicated rfa1 mutations either in an otherwise 
wild-type background (left) or in the cdc13-1 background (right) were grown at 24°C and 
telomere organization assessed by Southern blotting with a telomeric probe. A wild-type 
RFA1+ strain is illustrated as a control (wt). Following digestion of genomic DNAs with XhoI, 
the smear migrating at 1.1-1.4 Kb represents the average length of most telomeres, those 
containing Y’ subtelomeric regions. From non Y’-chromosomes, XhoI cutting typically 
generates fragments migrating at ~2.1, 2.3, 3.2 and 3.9 Kb in Southerns. (B) The cdc13-1 
rfa1-12 mutant exhibited telomere recombination following growth at 29°C on solid medium, 
here after 5 passages, one passage corresponding to restreaking of single colonies every 3 
days (~30 cell divisions per passage at 29°C). Meanwhile, increasing telomere uncapping by 
growing the other cdc13-1 rfa1 strains at 29°C (compared with growth at 24°C in panel A) led 
to substantial changes in telomere length and organization, different from one rfa1 mutant to 
the next, but, unlike with the cdc13-1 rfa1-12 mutant, not to telomeric recombination. 
Telomere organization in the cdc13-1 mec3, cdc13-1 bmh1 and cdc13-1 exo1 strains, all 
exhibiting deregulated growth at 29°C (see main text), is shown for comparison. 
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Figure 5. Improved growth in cdc13-1 rfa1-12 can take place in the absence of Rad52-
dependent telomeric recombination. (A) cdc13-1 rfa1-12 cells exhibited deregulated growth 
at 29°C even the absence of telomere recombination due to RAD52 deletion. (B) Kinetics for 
reaching telomere recombination upon telomere uncapping, at 27.5°C, in the cdc13-1 rfa1-12 
mutant cells. Sister cells deleted for RAD52 were grown and analyzed in parallel. See main 
text for more detail on the experimental set-up. 
 
Figure 6. Tel1 kinase activity and EST2/telomerase are required for the deregulated growth 
conferred by the rfa1 mutations upon telomere uncapping by cdc13-1. (A) Deletion of TEL1 
suppressed improved growth of the cdc13-1 rfa1-12 mutant and partially suppressed that of 
cdc13-1 rfa1-1. (B) Top panels: Expression of a kinase dead allele of tel1 (tel1-kd) from 
TEL1 genomic locus also suppressed improved growth of the cdc13-1 rfa1 mutants to 
various extents depending on the rfa1 mutation. Bottom panel: In the absence of incurred 
damage, the simultaneous presence of one of the analyzed rfa1 mutations and of the tel1-kd 
mutation did not interfere with cell growth. (C) Telomere length was measured by Southern 
blot (P32-TG1-3 probe, genomic DNA digested with XhoI) in strains with the indicated relevant 
genotypes. The est2-DF338 mutation conferred roughly equal telomere shortening in all rfa1 
mutant strains, as well as in the wild type (left panel). Right panel shows telomere 
shortening in tel1 and rad50 null strains for comparison. (D) The est2-DF338 mutation 
suppressed deregulated improved growth conferred by the rfa1 mutations in cdc13-1 
mutants with uncapped telomeres, at 27.5 or 29°C. 
 
Figure 7. Growth advantage conferred by the rfa1-1, rfa1-9, rfa1-10, rfa1-1 and rfa1-12 
mutations is not additive with that conferred by telomeric recombination. Telomeric 
recombination (as shown in Figure 1B) in post-senescence type II survivors, generated 
following genetic inactivation of telomerase (tlc1 disruption alone or in conjunction with the 
est2-DF338 mutation), led to improved growth at 27.5-29°C as expected (see Figure 1A, B). 
However, under these conditions the rfa1-1 mutants no longer grew better than the sister 
RFA1+ cells. 
 
1 
 
 
Table 1. Sequence analysis of the amino acid changes in the rfa1 alleles analyzed in the 
present study*. 
__________________________________________________________________________ 
Rfa1-1: I89T, T116S, S160P, D240G, T346P, D415N, D465V, T510S, E562G, Y575C 
Rfa1-9: S108P, H299D, N310S, V317I, N368Y, S487T, Q571R 
Rfa1-10: F269L 
Rfa1-11: F238L, Q428R 
Rfa1-12: L227S 
__________________________________________________________________________ 
* Rfa1-1 and Rfa1-9 mutations have already been reported in Grandin and Charbonneau 
(2007), but are also shown here for convenience. 
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